Stocks
Roche Holding AGRHHBY
OTCHealthcarePharmaceuticals$50.12-3.49%
Swiss-based pharmaceutical and diagnostics manufacturer focused on oncology, immunology, infectious diseases, and neuroscience, with a leading global diagnostics franchise. The company generates the majority of its revenue from patented biologic drugs, making pipeline development, clinical trial data, and patent expirations central to its valuation. Investors closely monitor its oncology portfolio, biosimilar competition, and the performance of its diagnostics division as key drivers of earnings stability and growth.
Market Cap: $322.8B52W Range: $34.75 – $60.85
Congressional Interest in Roche Holding AG (RHHBY)
12 members of Congress have disclosed 50 trades in Roche Holding AG (RHHBY), a Healthcare company. The buy/sell breakdown shows 29 purchases versus 21 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
12
Buys
29
Sells
21
Who in Congress Is Trading RHHBY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-10-03 | Mikie Sherrill | buy | $1K – $15K |
| 2019-08-20 | Josh Gottheimer | buy | $1K – $15K |